Metabolism of Serum Albumin in Tumour-Bearing Rats by Hradec, J.
290
METABOLISM OF SERUM ALBUMIN IN TUMOUR-BEARING RATS
J. HRADEC
From the Department of Biochemistry, Oncological Institute,
Prague, Czechoslovakia
Received for publication February 20, 1958
A LOWERING of the serum albumin level is a common accompaniment of
malignant disease in man (Mider, Alling and Morton, 1950) and of the growth
of experimental tumours in animals (Hradec, Dusek and Dlouh'a, 1954). The
mechanism whereby this hypoalbuminaemia is produced is still obscure.
Two factors must be taken into account when trying to explain this pheno-
menon, namely, the intensity of biosynthesis of serum albumin in cancerous
subjects, and the extent of utilization of this protein within the body (Fenninger
and Mider, 1954). The liver is the main, if not the only, seat of albumin produc-
tion as shown by experiments with hepatectomized animals (Madden and Whipple,
1940). A net synthesis of this protein has also been demonstrated in vitro by
incubating liverslices in a suitable medium (Peters and Anfinsen, 1950). Although
many studies of liver function have been undertaken in cancer patients and
some degree of impairment has been shown in a high percentage of them (Tagnon
and Trunnell, 1948), there is as yet no answer to the question whether a decline of
serum albumin synthesis in livers of cancerous subjects is the real reason for
hypoalbuminaemia occurring in blood. Lack of a suitable definition of this
hepatic dysfunction makes it difficult to interpret these results (Fenninger and
Mider, 1954). Reports from experiments undertaken in tumour-bearing animals
show an enlargement oflivers and kidneys while other organs undergo a reduction
in their size (Babson, 1954) An impairment of hepatic function can scarcely
be supposed in these cases. As it can be seen from these facts, no unequivocal
evidence exists up to date that hypoalbuminaemia in malignant diseases is due
to the lowered ability of the liver tissue to produce albumin.
There is good evidence for a demand for an increased supply of protein in
cancerous subjects. Tumours increase in size by the formation of new protein
molecules, for which an increased quantity ofbuilding materials must be available.
Since the liver holds a key position in the nitrogen metabolism of the body, the
suggestion has been made that the liver hypertrophy in rats bearing transplantable
tumours is in response to the tumour's demand for an increased supply of protein
(Babson, 1954). It is a well-known fact that tissues are able to utilize plasma
proteins for the formation of their own proteins, as was demonstrated in dogs
given plasma proteins parenterally as the only source ofnitrogen (Terry, Sandrock,
Nye and Whipple, 1948). Good evidence has also been obtained that a tumour
can efficiently utilize plasma proteins for tumour protein production (Babson and
Winnick, 1954). In keeping with these assumptions of increased utilization of
serum albumin in cancerous subjects is the demonstration of a faster rate of
loss of labelled albumin from the circulation of tumour-bearing rats (Babson,
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synthesis in the livers of these animals can be reached unequivocal evidence was
obtained of a higher demand for serum proteins in rats bearing transplanted
tumours.
No attempts at correlating these data have so far been reported and no direct
experimental proof has as yet been given for an altered serum albumin biosyn-
thesis in tumour-bearing animals. A mere study of the turn-over rate of this
protein in vivo cannot solve the problem, as at least two factors, degradation and
synthesis of new protein molecules, are concerned in experiments of this type.
In our laboratory, we tried to study both these factors separately and obtained
good evidence that increased intensity ofserum albumin formation accompanying
a faster rate ofloss ofthis protein from the circulation in tumour-bearing animals
may have some connection with the hypoalbuminaemia in these conditions.
MATERIALS AND METHODS
Experimental animals
Atotal of 195 Wistarrats ofboth sexes, weighing 150-200 g., was usedthrough-
out our experiments. The animals were housed in glass cages and given tap water
ad libitum. In most instances, they were fed the semisynthetic Larsen diet
(Jelinek, 1952, personal communication), in some cases diets rich in proteins,
carbohydrates or fat were given. The protein-rich diet consisted of casein and
normal Larsen diet (4: 1), the carbohydrate diet ofstarch and normal Larsen diet
(4: 1) and the fat-rich diet contained vegetable fat and normal Larsen diet
(1: 4). Each animal obtained 150 g. of this food daily.
Blood was withdrawn by cardiac puncture under ether anaesthesia, 1.5 ml.
being usually taken and mixed with 0 5 ml. of isotonic sodium citrate solution.
Bleedings were made on alternate days in short-lasting experiments (usually 3
times from one animal), and twice a week in long term series (6-8 times in one
animal). An equivalent volume of saline was given intraperitoneally to all
animals bled.
Tumours
The Walker 256 carcinoma and the 2056 sarcoma of this laboratory (Trojan
and Hradec, 1958) were used in our experiments. Tumours were implanted by
the trocar technique. Growth rates of the tumours were calculated from the
volumes ofplaster casts prepared on alternate days. The magnitute ofthe tumour
was expressed as the weight of the fresh tumour tissue excised in toto from sacri-
ficed animals.
Radioactive substances
Labelled (S35) dl-methionine with an average activity of 0-6-07 mc. per mg.
was obtained from the Radiological Research Institute in Prague. Internally
labelled (S35) rat serum albumin was prepared biosynthetically in this laboratory
and had an activity of 03-0 7 uc. per mg. in various batches. It was separated
by a cellulose column electrophoresis essentially according to Flodin and Porath
(1954) from blood-plasma of rats given intravenously labelled methionine or
yeast-protein hydrolysate. Details ofthis procedure are given in our subsequent
paper (Hradec, 1958a).
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Labelled compounds were administered to animals in most cases intravenously
in 0*1-0 2 ml. ofisotonic saline solutions. In this case 3-5 mg. of serum albumin
or 0 005-0 01 mg. of methionine were given per rat. In some cases labelled
methionine or labelled yeast were given orally in diluted milk in doses 0-02-0-05
mg. and 15-20 mg., respectively, per animal.
In vitro procedures
Normal and tumour-bearing animals were killed by a blow on the head, and
liver tissue was immediately removed and placed in cold isotonic saline. Tissue
slices were made by the Stadie-Riggs slicer (Stadie and Riggs, 1944) and were. then
suspended inice-cold saline andshakenthreetimes for two minutes in a mechanical
shaking-device, with three or four subsequent washings in ice-cold saline till the
washing-fluid was clear and uncoloured (Peters and Anfinsen, 1950). This treat-
ment lowered the blank albumin contents of the tissue to 10-20 per cent of its
original value. Afterthis, 0-5 g. ofwet slices were suspended in 3 ml. ofincubation
mixture (Krebs-Ringerbicarbonate (Krebs andHenseleit,1932) withoutphosphate)
in individual Warburg flasks and shaken gently in a Warburg apparatus for 2
hours at 37.50 C. in a gas atmosphere of 95 per cent 02 and 5 per cent C02. After
incubation the contents of each flask were homogenized in a glass homogenizer
and the homogenate centrifuged for 10 minutes at 18,000 G. The clear, slightly
opalescent supernatant was used for determination of albumin by an isotopic-
dilution procedure given next.
Chemical methods
Determination of the serum albumin level in rat plasma was performed by
filter paper electrophoresis. A wet-chamber technique, using Barbital-citrate
buffer, pH 8-5, tu 0-067, Whatman No. 1 paper andapotential gradientof 8 Vper
cm. was used. After drying the paper, proteins were stained by bromphenol
blue, strips ofpaper corresponding to each one plasma protein fraction eluted and
the percentage ofthedyeadsorbeddeterminedinaLangephotoelectric colorimeter.
For the determination of the radioactivity of the serum albumin, the plasma
proteins were precipitated by trichloracetic acid, the precipitate washed by the
samed acid, the albumin extracted with ethanol (Korner and Debro, 1956) and
precipitated from this solution by ether. After several washings the precipitate
was collected on filter-paper discs and its radioactivity counted. Details of the
procedure ofalbumin isolation are given in our subsequent paper (Hradec, 1958a).
Net production of serum albumin in liver slices was determined by an isotope-
dilution procedure. Pure labelled albumin was added to supernatants of incu-
bation-mixture homogenates as described above, the proteins were precipitated
with trichloracetic acid and serum albumin extracted from the precipitate in
the same manner as described in the above paragraph. From the value ofspecific
radioactivity of the washed albumin precipitate the concentration of serum
albumin in the sample was calculated using a calibration chart made from specific
activities of samples to which known quantities of pure serum albumin had been
added. Details of this procedure are given in a subsequent paper (Hradec,
1958b). Blank samples for the determination of initial serum albumin level
in slices before incubation were prepared in the same way from the washed liver
slices as samples incubated. They were prepared immediately before incubation
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and placed after homogenization and centrifugation in a deep-freezing unit to
minimize possible proteolytic processes. Further elaboration of these blank
samples then proceeded together with samples after incubation. Values of
initial serum albumin level in slices varied between 1F8-3-2 mg. per g. of fresh
washed liver slices in different animals, respectively. Usually 4 blank and 6
incubated samples were analysed from the liver of one rat. The statistical error
of the determination did not exceed ±2 per cent in most instances and only
cases with a probable error lower than 3 per cent of the blank value were taken
into account in our experiments. For the calculation of net serum albumin
biosynthesis the blank value was subtracted from the value of incubated samples
and results expressed as mg. of serum albumin produced per g. of fresh liver
slices per hour.
Radioactivity assay
In all cases radioactivity was determined in precipitates finely homogenized
in a glass homogenizer and plated on tared filter-paper discs in a filtration device.
These samples were counted using a mica-window Geiger-Muller counter from a
distance of 20 mm. The counting period chosen was sufficiently long to minimize
the probable error to ±2 per cent. All samples were corrected for decay and
self-absorption when necessary.
RESULTS
Turn-over rate of serum albumin in normal animals
Two different values for the biological half-life ofserum albumin were obtained
depending on the mode of administration of radioactive substances. When
labelled methionine was given either orally or by intravenous or intraperitoneal
injection, decline of the labelled serum albumin in the blood-plasma of normal
animals followed a straight exponential slope from the 7th hour till the 4th week
after administration. A more detailed survey of this dependence revealed it to
be more complicated with several risings and fallings of the curve. An average
value of these results gave 4.47 days for the biological half-life of serum albumin,
which is in good agreement with figures given by other authors (Tarver and Morse
(1948) 4-4 days).
After administration of labelled pure serum albumin intravenously or labelled
yeast protein in food there was a straight exponential decline ofthe serum albumin
specific activity in blood-plasma steeper than in the previous case. This straight
line was followed for 3-5 days depending on the quantity of labelled substance
administered, after which a temporary rise in the level oflabelled serum albumin
appeared lasting only a few hours and followed by another decline of the curve.
The more radioactive substance was administered the later this ascent of the
specific activity-time relation line appeared. The decline of the curve after this
rise was more gradual than before. Further temporary ascent of the specific
activity appeared after varying periods of time again depending on the quantity
ofsubstance administered and after 3 or 4 ofthese risings the slope ofthe line was
the same as after labelled methionine administration and no additional risings
of the curve were found. The value of the biological half-life of serum albumin
calculated from the progress of the specific activity-time relation straight line
during the first 3 days after the administration of labelled substances gave 24
hours in normal animals.
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Biological half-life of serum albumin after various modes of administration
oflabelled substances is given in Fig. 1.
We assume that no fundamental difference exists between these two seemingly
quite dissimilar values for the turn-over time of serum albumin. The specific
activity-time relation curve is a result of two processes, the utilization of the
protein in the tissues and biosynthesis of new labelled albumin molecules in the
body. Where no free labelled amino acids are available for this biosynthesis,
the biological half-life is a result of a mere degradation of the labelled protein as
in the case of pure albumin administration. In the course of this degradation of
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FiG. 1.-The biological half-life of serum albumin in normal rats after intravenous administra-
tion of radioactive albumin (full line) or labelled methionine (dashed line). Average values
are given, based on the results of an experiment performed on 30 and 23 animals,
respectively.
labelled serum albumin, radioactive cystine and methionine are released, which
can be utilized for the formation of new serum albumin molecules synthesized
in the body. As soon as this occurs, these newly formed protein molecules must
be taken into account, in the interpretation of the biological half-life curve.
In this way the temporary ascents of the curve when most of the administered
albumin has been degraded can be explained, and also the constantly more gradual
slope of the labelled albumin level curve. A dynamic balance must be achieved
between the processes of albumin degradation and formation, respectively.
When this is done, the slope ofthe curve after about two weeks is exactly the same
as in the case of labelled methionine administration, where this balance can be
achieved during the first few hours after the administration.
No differences in the turn-over time of serum albumin were found in animals
fed on various diets. The slope of the labelled albumin-time relation curve was
the same in these animals as in those fed the standard Larsen diet. Significant
differences, however, were found in the initial labelled albumin level after feeding
labelled methionine. The specific radioactivity of serum albumin after admini-
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stration of a carbohydrate-rich diet was about twice as high as in animals fed
diets rich in fat. The protein-rich diet resulted in a slightly lower initial labelled
albumin level than the fat diet.
From these results it can be assumed that diet has no influence on the general
biosynthesis-degradation balance of serum albumin discussed in the previous
paragraph. It appears, however, that the utilization of labelled amino acids
for purposes other than albumin synthesis is higher in animals fed protein- and
fat-rich diets. Probably the undernourishment of these animals must also be
taken into account in explaining these facts.
All these facts are thoroughly discussed in our subsequent paper dealing with
the turn-over rate of serum albumin in normal rats (Hradec and Trojan, 1958).
Turn-over rate of serum albumin in tumour-bearing animals
A shortening of the turn-over time of serum albumin was found in all tumour-
bearing animals studied. This was the case in long-term experiments on animals
administered labelled methionine as well as in short-lasting experiments after
administration of labelled serum albumin intravenously. In experiments with
tumour-bearing animals fed various diets also a shortening of the biological
half-life of serum albumin was found after administration of labelled methionine
intraperitoneally.
A group of animals with Walker 256 tumours in the 2nd week after trans-
plantation (average tumour-weight 83 g.) showed a turn-over rate of serum
albumin equal to 16 hrs. The serum albumin level in the blood plasma of these
animals was also lowered to between 50 and 80 per cent of its normal value.
In another group of rats in the first week after the transplantation of Walker
256 carcinoma, in which blood was taken from the 2nd day after transplantation,
tumours having been scarcely palpable in the majority ofthese animals, the same
value, i.e. 16 hours, was found for the biological half-life of serum albumin. The
plasma albumin level in these animals was within the ranges found in normal
rats.
An examination of the albumin turn-over rate in rats with giant Walker
tumours ante finem (4-5th week after transplantation, average tumour weight
32*4 g.) revealed the same value as in previous experiments, although the plasma
albumin level in these animals was in all cases significantly lowered (under 50
per cent ofits original value).
The experiments cited above also showed that changes in the rate of growth
of the tumour in its various growth-periods did not alter the turn-over rate of
serum albumin, which remained at the same value, i.e. 16 hours. This mutual
independence of the growth-rate of a tumour and the lowered value of serum
albunmin turn-over rate was clearly demonstrated in subsequent experiments,
in which rats implanted with the 2056 tumour were used. Although this sarcoma
grows more quickly than the Walker carcinoma and kills the animal after 18-24
days the same value for the biological half-life of albumin was found in these
animals as in those bearing the Walker carcinoma. Again, the growth-stage of
the tumour was without significance for the turn-over time of serum albunmin,
the same value being found in animals in their first week after transplantation
as well as in those bearing giant tumours immediately before death; nor was
a correlation discovered between the serum albumin level in plasma and its
turn-over rate, as mentioned when describing experiments with the Walker
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256 carcinoma. The results of these short-lasting experiments are shown in
Fig. 2.
Similar results were obtained in the long-term experiments, also. In several
groups of animals bearing either the Walker 256 carcinoma or a 2056 sarcoma
the turn-over rate of serum albumin was followed, from the first week after
transplantation up to the endofanimals'lives, aftertheintravenous administration
of labelled methionine. A value of 3*90 days (corresponding to 4*47 days in
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FIG. 2.-Turn-over rate ofserum albumin after intravenous administration oflabelled albumin
in normal (full line) and tumour-bearing animals (dashed line). Average values are given
from anexperiment on 30 and 32 animalsrespectively.
normal animals) was found in all tumour-bearing animals. The slope of the
labelled albumin-time relation curve was straight during the whole of this period
of time, again clearly demonstrating that no correlation exists between the turn-
over rate and the growth-rate of the tumour and serum albumin level in blood
plasma, respectively. Valuesforserumalbuminspecificradioactivityinindividual
animals varied within limits of ±1O per cent.
Results of long-term experiments on rats given various diets after admini-
stration of labelled methionine intraperitoneally did not differ from those given
above. Some difficulties were found in growing the tumours, especially in rats
on a protein-rich diet, the turn-over rate ofserum albumin in the tumour-bearing
animals being the same as in those fed on the Larsen diet.
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The turn-over rate of serum albumin in long-term experiments is given in
Fig. 3.
In a few animals in which tumours did not "take ", the biological half-life
of serum albumin did not differ from in normal ones.
In some groups oftumour-bearing animals somewhat involuntary experiments
were made. Tumours in these animals regressed after various periods of normal
growth. In some ofthem after one week's growth suppuration occurred followed
by ulceration, and scarred skin remained instead of tumours. Another group
showed macroscopically normal tumour growth for a period of 2 weeks, but
autopsyshowedanabscess, with occasional remains of tumour tissue or noneat all.
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FIG. 3.-Turn-over rate of serum albumin after intravenous administration of labelled
methionine in normal (full line) and tumour-bearing animals (dashed line). Average values
from experiments on 23 and 20 animals, respectively, are given.
Examination of the turn-over time of serum albumin in these animals revealed
very interesting findings. Contrary to the results obtained in animals with
growing tumours, the biological half-life of serum albumin in these animals
showed a prolongation in comparison to the value stated in normal animals.
The plasma albumin level in these animals was lowered to the same extent as in
those bearing progressively growing tumours. Results of these experiments
are given in Fig. 4.
In most cases a more complicated slope of the specific radioactivity-time
relation curve could be observed, which consisted of three phases. In the first
phase-active tumour growth-the slope of the curve could not be distinguished
fromthat oftumour-bearing animals; inthesecondphase-the regressionperiod-
a prolongation of the biological half-life of albumin occurred, and in the third
phase-the healing period-a turn-over rate equal to that in normal animals
was found. The first two phases could not be distinguished macroscopically.
In most animals palpable tumours in the second phase did not differ from actively
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growing ones and only autopsy showed the true state of affairs. It was possible
in some cases, from the mere turn-over rate of serum albumin, to conclude the
true fate of a tumour, indistinguishable from the other active-growing ones.
Return to the normal biological half-life serum albumin occurred at the time
when skin ulcerations and scars were healing. Usually only two of these phases
could be followed in short-term experiments, as in Fig. 4.
2
Days
3 4
FIG. 4.-Turn-over rate of serum albumin after intravenous administration oflabelled albumin
in normal (dashed line) and regressing tumour-bearing animals (full lines). In one case the
regression period is seen (0 0), in qthers the change from regression to normal
growth period (O 0), and from the tumour growth to regression period
( x x ), respectively, is visible. All values were obtained in individual animals.
Incorporation of labelled methionine into serum albumin in tumour-bearing rats
When labelled methionine was administered intravenously to normal rats,
a steep ascent of the serum albumin specific radioactivity in blood-plasma could
be observed during the first hour after the injection. A second period followed
in which logarithmic values of serum albumin radioactivity plotted against the
linear values of time gave a straight line for the next 3-4 hours. After this
there was a decline followed by a second increase of radioactive albumin in blood
plasma.
In tumour-bearing animals, the top ofthe first phase was achieved in a shorter
period of time and the value of its was higher than in normal animals. The
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serum albumin specific activity in the second period also showed higher values
than those found in normal animals and the slope of the curve was steeper.
Decline of the curve after this period occurred earlier than in normal animals.
Results of these experiments are shown in Fig. 5.
These results indicate a higher incorporation of labelled methionine into
albumin in tumour-bearing animals. Corresponding to the results obtained by
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FIG. 5.-Incorporation of labelled methionine into serum albumin after intravenous admini-
stration of this amino acid in normal (full line) and tumour-bearing animals (dashed line).
Each point of the line represents an average of values obtained from 3 to 4 animals.
studying the turn-over of serum albumin it is evident that a more thorough
utilization of serum albumin takes place in tumour-bearing animals, as shown
by the earlier decline ofthe specific activity-time relation curve in this group.
In agreement with these results, the specific radioactivity of serum albumin
in animals with tumours in regression showed a smaller top of the first period
than the normal animals. The values of radioactive alburmin in the second
period were also smaller and the decline of the curve occurred later than in the
controls. These results are given in Fig. 6 and indicate a worse utilization of
serum albumin in these animals in comparison with normal ones.
Net production of serum albumin by liver slices
When liver slices of normal rats were incubated in the medium given above,
an average value of new-formed albumin equalled 0-42 mg. per hour per g. of
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wet tissue. Livers of tumour-bearing animals showed a higher intensity of this
process and an average net production of serum albumin comprised 1V23 mg.
per hour per g. ofwet tissue. As can be seen from Table I, results in the tumour-
bearing group showed a higher dispersion of values than in control animals,
but the lowest amount of serum albumin synthesized by livers of tumour-bearing
animals was still higher than the highest figures found in the normal group.
Only in 2 animals in this group were values similar to those in normal rats found.
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FIG. 6.-Incorporation of labelled methionine into serum albumin after intravenous admini-
stration of this amino acid in normal (full line) and regressing tumour-bearing animals
(dashed line). Each point on the line represents an average ofvalues obtained in 3 animals.
TABLE I.-Net Production ofSerum Albumin in vitro in Normal
and Tumour-bearing Animals
Normal animals
Tumour-bearing animals
Number
of animals
26
21
Net production of serum albumin
Average a Ranges
0-42 ±0d14 018-0*56
1-23 +048 048-2-05
(mg. per hr. per g. of liver slices)
When a possible correlation between tumour volume and the intensity of
serum albumin biosynthesis was tested for, no connection could be found, as is
clearly visible from Fig. 7. In some cases animals bearing small tumour nodules
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showed a very high intensity of net production of serum albumin in contrast to
those with giant tumours, in which a much smaller quantity of this protein
was formed.
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FIG. 7.-Relation between tumour weight and the production of serum albumin in liver slices.
DISCUSSION
Direct evidence has been obtained in ourexperiments ofintensified production
of serum albumin in the liver-tissue of tumour-bearing animals. The suggestion
that reduced albumin synthesis in cancerous subjects is the cause ofhypoalbumi-
naemia in them can therefore be excluded. A higher demand for serum albumin
occurs in tumour-bearing animals, as seen unequivocally from its more intensive
formation and a faster turn-over rate. However, these two facts alone are not
sufficient in considering possible causes of hypoalbuminaemia in these animals.
A higher degradation of albumin being compensated for by its higher production
need not lead to abnormality in its blood-plasma level.
Another fact must be taken into account in considering the mechanism of
hypoalbuminaemia in malignant diseases. It was shown in our experiments
that the same turn-over rate of albumin takes place in tumour-bearing animals
without dependence on the growth-rate or magnitude of the tumour. Although
no straightforward relationship could be found between the extent of serum
albuminsynthesis andthe volume oftumourtissue, extensive individual variations
wererevealed inthisrespect. It couldbe assumedfromthisfact thattheincreased
demand ofthe tumour for a supply ofserum albumin cannot be met by intensified
synthesis of this protein in the liver in every case. From this it follows that in
these cases the degradation processes rise over the production and it seems
obvious that this quantity must be repaid from the protein circulating normally
in blood-plasma, leading in this way to a decline in its level. It is well known
that wide individual differences exist in plasma albumin levels in cancer patients
(Fenninger and Mider, 1954) and tumour-bearing animals also (Hradec, Dusek
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and Dlouha, 1954) and these could be explained by the differing ability of the
liver tissue of such beings to intensify its albumin production. From this point
of view it is quite understandable that in some individuals a greater decline
of the serum albumin level in the plasma occurs early in this disease while in
others only a slight decrease of the serum albumin could be observed even in the
terminal stages.
The results of our in vivo experiments showed a shortening of the biological
half-line ofserum albumin practically from the first moment oftumour "taking ".
A reason must be searched for, why in animals, in which an ability to produce a
sufficiently higher amount of albumin is not provided, no decline of plasma
albumin level occurs during the first few days. We assume that this increased
amount of albumin is repaid from some reserves of this protein in these early
stages. Good evidence was obtained for there being a stock of this protein at
disposal in the liver tissue. In some in vitro experiments we observed a very
low initial level of albumin in the liver slices of tumour-bearing animals before
incubation amounting to only 20-30 per cent of the quantity usually present in
the livers of normal or other tumour-bearing animals. According to our suppo-
sition these stock amounts ofalbunmin are first of all utilized in those cases where
no sufficient production of this protein can be provided to meet the increased
demand for it. Not until these reserves are exhausted is albumin circulating in
the blood-plasma utilized, thus leading to a decline in its level.
A diverse situation was found in animals with regressing tumours. A prolon-
gation of the biological half-life of alb-umin could be observed, indicating a greater
amount ofthisproteinhaving been at disposal than could be utilized. In addition,
a decreased intensity of serum albumin biosynthesis could be deduced from the
fact that a lowerincorporation oflabelled methionine into serumalburmin resulted
after administration of this amino acid. It follows from these experiments, too,
that the presence of an actively growing tumour is a necessary condition for a
higher demand of serum albumin. Another conclusion can be reached from
these results. In both active-growing tumour-bearing animals and in those with
tumours in regression (chronic suppuration, in fact) a lowering of the serum
albumin level in the blood plasma occurred, the mechanism of this being quite
dissimilar in both instances, accompanied by a decline or prolongation of the
turn-over time, respectively.
Without considering the possible evaluation of these results in diagnosis
a question arises regarding the mutual relations of tumour- and liver-tissue in
tumour-bearing animals in utilization and production of serum albumin, respec-
tively. No definite conclusions can be drawn to date as to the mechanism of
increased albumin formation in animals bearing transplanted tumours. More
detailed studies of tumour-host relationships now in progress in this laboratory
may throw some light in this problem and indicate whether a factor originating
somewhere in the tumour-bearing individual plays a part in the stimulation of
serum albumin biosynthesis.
The same turn-over rate of serum albumin in animals immediately after the
transplantation as in those bearing giant tumours scarcely allows an assumption
of this protein being utilized entirely for tumour protein production. It is
beyond dispute that some quantity ofit must be used, possibly without extensive
degradation, for tumour protein synthesis, as found by Babson and Winnick
(1954). It is obvious, however, that this synthesis cannot be so intensive in the
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early stages as in the late ones. Another possibility exists that some transfor-
mation of serum albumin into other blood-protein molecules takes place, as
claimed by Roberts (1954) for lymphosarcoma tissue. Mucoproteins of an alpha-
globulin mobility increase in tumour-bearing animals (Winzler, 1953) providing
evidence that such a transformation may exist in other tumour tissues, too.
For the early stages oftumour growth, however, a general mobilization ofprotein
metabolism must be taken into account in explaining the higher turn-over rate
of serum albumin. Further studies are in progress in this laboratory using
benzpyrene-induced tumours, which allow a more detailed investigation of these
early stages than transplanted ones.
SUMMARY
1. After administration ofinternally-labelled (S35) serum albumin the biological
half-life ofthis protein was 24 hrs. in normal rats. When labelled (S35) methionine
was given intravenously or intraperitoneally a serum albumin turn-over rate of
4.47 days resulted. If the turn-over rate of a protein is regarded as being a
result ofbiosynthetic and degradation processes, these differences can be explained
on the basis of free labelled amino acids present in the body.
2. Tumour-bearing animals showed a decline in the turnover rate of serum
albumin. A value of 16 hrs. and 3-8 days, respectively, was found in all experi-
mental groups irrespective of the magnitude and growth-rate of the tumour.
3. Rats with regressing and suppurating tumours showed a prolongation of
the biological half-life of serum albumin.
4. When labelled methionine was administered to tumour-bearing animals,
a higher activity in serum albumin was found than in the controls and animals
with regressing tumours, which showed a less intensive incorporation than the
normal ones.
5. Liver slices of tumo-ur-bearing animals produced in vitro a greater amount
of serum albumin than did the controls. No correlation between this intensified
synthesis and the magnitude of the tumour was found.
6. It is supposed that increased albumin biosynthesis together with its higher
turnover rate give evidence of a higher demand for serum albumin in tumour-
bearing animals, which can be utilized for tumour protein synthesis, transfor-
mation into other plasma proteins, and other purposes.
7. A decreased ability of the liver-tissue in individual animals to form serum
albumin in sufficient quantities to meet the increased demand for it, together
with exhaustion of the stock reserves of this protein in the liver, is assumed to
be the ultimate cause ofhypoalbuminaemia in tumour-bearing animals.
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